I-Tech AB (STO:ITECH)
| Market Cap | 677.87M |
| Revenue (ttm) | 168.12M |
| Net Income (ttm) | 33.19M |
| Shares Out | 12.00M |
| EPS (ttm) | 2.79 |
| PE Ratio | 20.27 |
| Forward PE | 14.49 |
| Dividend | 1.25 (2.29%) |
| Ex-Dividend Date | May 16, 2025 |
| Volume | 10,442 |
| Average Volume | 13,896 |
| Open | 52.90 |
| Previous Close | 54.50 |
| Day's Range | 52.90 - 56.90 |
| 52-Week Range | 42.20 - 124.50 |
| Beta | 0.73 |
| RSI | 67.22 |
| Earnings Date | Apr 17, 2026 |
About I-Tech AB
I-Tech AB, a biotechnology company, develops, markets, and sells antifouling coating products in Sweden. The company offers Selektope, an organic, metal-free biocide used as a component in marine antifouling paints to prevent barnacles from settling on coated surfaces. It serves cleantech sector and marine paint industry. I-Tech AB was founded in 1990 and is based in Mölndal, Sweden. [Read more]
Financial Performance
In 2025, I-Tech AB's revenue was 168.12 million, a decrease of -6.32% compared to the previous year's 179.45 million. Earnings were 33.19 million, a decrease of -14.92%.
Financial StatementsNews
I-Tech AB Earnings Call Transcript: Q4 2025
Q4 2025 saw a 33% drop in net sales and a 5% decline in EBITDA, but gross margin improved to 57% and cash flow remained strong. Growth was driven by China and smaller customers, while regulatory and currency headwinds persisted. Dividend increase proposed to SEK 1.25 per share.
I-Tech AB Earnings Call Transcript: Q3 2025
Third strongest quarter ever with 10% organic sales growth and strong cash flow, despite customer-specific headwinds. Gross margin and EBITDA margin improved, while regulatory costs rose due to EU re-registration. New partnerships and product launches are expected to drive future growth.
I-Tech AB Earnings Call Transcript: Q2 2025
Q2 2025 saw a 26% drop in net sales due to inventory effects and market turbulence, but gross margin improved to 59% and H1 EBITDA margin reached 30%. The business remains strong in Asia, with smaller customers and innovation projects driving future growth.
I-Tech AB Earnings Call Transcript: Q1 2025
Q1 2025 saw net sales up nearly 50% year-over-year, with record EBITDA margin and strong cash flow. Asia drove 99% of sales, with China growing fastest, while regulatory and currency headwinds are expected to increase volatility and costs in coming quarters.
I-Tech AB Transcript: GoCo Investor Day 2025
Strong growth driven by innovative antifouling technology, with Asia as the main market and ongoing regulatory efforts in the EU and US. Financials show robust revenue and margin expansion, with a rising dividend and plans for further business development and operational improvements.
I-Tech AB Earnings Call Transcript: Q4 2024
Achieved record sales and profit in 2024, driven by nearly 50% sales growth and strong Asian market demand. Regulatory renewal in the EU remains a key focus, with industry support and ongoing investments in operational improvements and business development.
I-Tech AB Transcript: ABGSC Investor Days
A unique anti-fouling technology is driving growth in the maritime coatings market, with strong sales in Asia and expanding adoption among major paint manufacturers. Regulatory challenges in Europe are being addressed, while R&D and new market entries support future growth.
I-Tech AB Earnings Call Transcript: Q3 2024
Q3 saw 27% sales growth and a 23% operating margin, with strong cash flow and a healthy balance sheet. Regulatory risks in the EU persist, but business development and supply chain improvements are underway, supporting continued growth and market expansion.
I-Tech AB Transcript: Fireside Chat
Magnus Henell discussed strong growth driven by premium paint trends, Asian market dominance, and ongoing regulatory challenges. Product innovation and new customer launches are expected to further expand market reach, with a new CEO set to drive strategic growth.
I-Tech AB Earnings Call Transcript: Q2 2024
Record sales and profit driven by strong growth in Japan and Korea, with Selektope now used on over 2,500 ships. EU regulatory renewal remains a key risk, but ongoing stakeholder engagement and a positive market outlook support continued expansion.